Vanguard Personalized Indexing Management
TEVA icon

Vanguard Personalized Indexing Management’s Teva Pharmaceuticals TEVA Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
37,768
+4,063
+12% +$135K 0.01% 855
2026
Q1 		$1.02M Sell
33,705
-3,216
-9% -$103K 0.01% 925
2025
Q4 		$1.15M Buy
36,921
+449
+1% +$11.1K 0.01% 846
2025
Q3 		$737K Buy
36,472
+1,198
+3% +$21K 0.01% 1056
2025
Q2 		$591K Buy
35,274
+8,192
+30% +$132K 0.01% 1122
2025
Q1 		$416K Sell
27,082
-7,625
-22% -$136K 0.01% 1194
2024
Q4 		$765K Buy
34,707
+4,132
+14% +$75.2K 0.01% 911
2024
Q3 		$551K Buy
30,575
+2,932
+11% +$51.3K 0.01% 1050
2024
Q2 		$449K Buy
27,643
+5,831
+27% +$89.8K 0.01% 1085
2024
Q1 		$308K Buy
21,812
+5,674
+35% +$71.5K 0.01% 1250
2023
Q4 		$168K Buy
16,138
+2,041
+14% +$19.1K ﹤0.01% 1434
2023
Q3 		$144K Buy
+14,097
New +$131K ﹤0.01% 1343
2023
Q2 		– Sell
-11,315
Closed -$100K – 1525
2023
Q1 		$100K Buy
11,315
+813
+8% +$8.04K ﹤0.01% 1402
2022
Q4 		$95.8K Sell
10,502
-280
-3% -$2.44K ﹤0.01% 1223
2022
Q3 		$87K Buy
+10,782
New +$95.3K ﹤0.01% 1178

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Vanguard Personalized Indexing Management's TEVA Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Teva Pharmaceuticals (TEVA) stake by 12% in Q2 2026, buying an estimated $135K and bringing the position to 37,768 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #855.

Vanguard Personalized Indexing Management first reported a position in TEVA in Q3 2022 and has held it in 15 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Vanguard Personalized Indexing Management held 37,768 shares of Teva Pharmaceuticals worth $1.28M as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 4,063 Teva Pharmaceuticals shares in Q2 2026, an estimated $135K.
  • Teva Pharmaceuticals made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #855 holding.
  • Vanguard Personalized Indexing Management first reported a position in Teva Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.